跳至主要内容
临床试验/NCT00140205
NCT00140205已完成1 期

Pharmacokinetics of Leptin Administration During Fasting

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2001年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
15
试验地点
1
主要终点
Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

研究概览

简要总结

The purpose of this study will be to determine the correct dose of leptin, a natural hormone secreted by the fat cells, to give to people when they are fasting and also to determine whether giving leptin to a person when he or she is fasting will reverse the changes in hormone levels that occur with fasting.

详细描述

Leptin is a newly-identified hormone secreted by fat cells under normal conditions that acts in the brain to decrease appetite and increase long term energy usage. Leptin levels usually go down when people are not eating for extended periods of time. Changes in metabolism and certain hormone levels also occur with fasting. By studying the pharmacokinetics of leptin administration, we can evaluate the changes of leptin levels in response to giving different doses of leptin as well as acute changes of other hormones in response to leptin levels. Investigations such as this one have important implications for the future therapeutic use of leptin, including determining the appropriate dose of leptin to use in future studies involving leptin administration.

Comparison: subjects receiving leptin at 3 different doses in the fed state compared to the fasting state

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy men with body mass indices (BMI) <25 kg/m2)
  • overweight otherwise healthy men with BMI > 27 kg/m2
  • healthy lean women with BMI<25 kg/m2
  • overweight otherwise healthy women with BMI > 27 kg/m2

排除标准

  • history of any illness that may affect the concentrations of the hormones that will be studied (such as anemia, infectious diseases, renal or hepatic failure, diabetes mellitus, cancer, lymphoma, hypogonadism, malabsorption or malnourishment, hypo or hyperthyroidism, hypercortisolism, alcoholism or drug abuse, eating disorders)
  • on medications known to affect the hormones to be measured in this study (such as glucocorticoids, anti-seizure medications or thyroid hormones)
  • known history of anaphylaxis or anaphylactoid-like reactions or who have a known hypersensitivity to E. Coli derived proteins
  • women who are breast feeding, pregnant, or wanting to become pregnant during the next 6 months

研究组 & 干预措施

Fed state or fasting state

Experimental

1-day fed studies with administration of r-metHuLeptin at three different doses (0.01 mg/kg, 0.1 mg/kg, 0.3 mg/kg). All subjects participated in 3 studies in the fed condition (Part A) and 3 separate 72-hour fasting studies.

Intervention administered was-r-metreleptin in 3 different doses

干预措施: r-metHuLeptin (Drug)

结局指标

主要结局

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.1 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.3 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.3 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.01 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.01 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.01 mg/kg

Leptin Pharmacokinetic Parameters TIME(T1/2) DAY 3 / TMAX DAY 3 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetic Parameters - TIME(T1/2) / TMAX 24-hour Fed Leptin Dose 0.1 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.1 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 72-hour Fasting Day 3 Leptin Dose 0.1 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.1 mg/kg

Leptin Pharmacokinetics Parameters - AUC 72-hour Fasting Day 3 Leptin Dose 0.3 mg/kg

时间窗: 3 DAY

72-hour fasting Day 3 Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.3 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.3 mg/kg

Leptin Pharmacokinetics Parameters - c(MAX) / L0 (ENDOGENOUS LEPTIN LEVEL) 24-hour Fed Leptin Dose 0.01 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

Leptin Pharmacokinetics Parameters - AUC 24-hour Fed Leptin Dose 0.01 mg/kg

时间窗: 1 DAY

24-hour fed Leptin dose 0.01 mg/kg

次要结局

  • Cytokine Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(1 DAY or DAY 3)
  • Neuroendocrine Hormone Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(1 DAY or DAY 3)
  • Adipokine Hormone Levels 24h Fed or 72h Fasting for All Different Leptin Doses (0,01-0,1-0,3 mg/kg)(day 3 of fasting and day 1 of fed state)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christos Mantzoros

Professor of Medicine

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验